ACER - オペクサ・セラピュ―ティクス (Acer Therapeutics Inc.) オペクサ・セラピュ―ティクス

 ACERのチャート


 ACERの企業情報

symbol ACER
会社名 Acer Therapeutics Inc (オペクサ・セラピュ―ティクス)
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種 バイオテクノロジ―_メディカルリサ―チ   医療関連(Health Care)
概要 事業概要 オペクサ・セラピューティクス(Opexa Therapeutics Inc)はバイオ医薬品企業。同社は多発性硬化症(MS)などの疾患に対する治療の可能性のある個別化細胞療法の開発に従事する。それらの治療法は同社のT細胞技術をベースとしている。同社の主な製品候補であるTovaxinはベーラー医科大学(Baylor College of Medicine)からライセンスを受けた、MS治療用の臨床開発中の個別化T細胞治療ワクチンである。TcelnaはT細胞の免疫療法であり、IIb期臨床開発中の二次進行型MS(SPMS)治療用に使用される。Tcelnaは患者の疾患プロファイルに特に合わせる個人向け治療法である。TERMS研究は臨床分離症候群リスクの高いあるいは再発寛解型多発性硬化症(RRMS)を患っている150位患者を対象とする多中心の無作為プラセボ比較二重盲検臨床試験である。   オペクサ・セラピュ―ティクスは米国のバイオ医薬品会社。多発性硬化症(MS)など重篤な疾病、及び視神経脊髄炎などの免疫性疾患の自己免疫療法の開発に従事。独自に開発したT細胞技術に基づき、二次進行型MSや再発寛解型MSなどの治療薬の臨床開発段階にある。また、血液から単球由来幹細胞を生成するための成体幹細胞技術を開発。本社はテキサス州。   Acer Therapeutics, Inc. is a pharmaceutical company. The firm engages in the acquisition, development and commercialization of therapies for medical needs. Its product pipeline includes Edsivo and ACER-001. The Edsivo is a type of celiprolol for Vascular Ehlers-Danlos syndrome. The ACER-001 is for the treatment of urea cycle disorders and Maple Syrup Urine diseases. The company was founded by Christopher Schelling on September 19, 2017 and is headquartered in Newton, MA.
本社所在地 One Gateway Center Suite 351 300 Washington St. Newton MA 02458 USA
代表者氏名
代表者役職名
電話番号
設立年月日 33298
市場名 NASDAQ Small Cap
ipoyear ―年
従業員数 6人
url www.acertx.com
nasdaq_url https://www.nasdaq.com/symbol/acer
adr_tso
EBITDA EBITDA(百万ドル) -16.45878
終値(lastsale) 28.37
時価総額(marketcap) 285203269.56
時価総額 時価総額(百万ドル) 282.99160
売上高 売上高(百万ドル) 0.00000
企業価値(EV) 企業価値(EV)(百万ドル) 274.64783
当期純利益 当期純利益(百万ドル) -16.51118
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Acer Therapeutics Inc revenues was not reported. Net loss increased 36% to $8.8M. Higher net loss reflects General and administrative increase from $1.5M to $4.1M (expense). Basic Earnings per Share excluding Extraordinary Items decreased from -$1.01 to -$1.18.

 ACERのテクニカル分析


 ACERのニュース

   The Daily Biotech Pulse: Mylan Ramps Up Manufacturing Of Potential COVID-19 Drug, Lexicon Stops Study Early, Masimo To Buy German Ventilation Company  2020/03/20 11:44:59 Benzinga Feeds
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 19.) Biomerica, Inc. (NASDAQ: BMRA ) Centogene NV (NASDAQ: CNTG ) Gilead Sciences, Inc. (NASDAQ: GILD ) Imara Inc (NASDAQ: IMRA ) Regeneron Pharmaceuticals Inc (NASDAQ: REGN ) Down In The Dumps (Biotech stocks that hit 52-week lows March 19.) Acasti Pharma Inc (NASDAQ: ACST ) Accelerate Diagnostics Inc (NASDAQ: AXDX ) Acer Therapeutics Inc (NASDAQ: ACER ) Aclaris Therapeutics Inc (NASDAQ: ACRS ) Aerpio Pharmaceuticals Inc (NASDAQ: ARPO ) Aikido Pharma Inc (NASDAQ: AIKI ) Alpine Immune Sciences Inc (NASDAQ: ALPN ) Amphastar Pharmaceuticals Inc (NASDAQ: AMPH ) Anika Therapeutics Inc (NASDAQ: ANIK ) Anixa Biosciences Inc (NASDAQ: ANIX ) AnPac Bio-Medical Science Co Ltd – ADR (NASDAQ: ANPC ) Antares Pharma Inc (NASDAQ: ATRS ) Apyx Medical Corp (NASDAQ: APYX ) Arca Biopharma Inc (NASDAQ: ABIO ) Aridis Pharmaceuticals Inc (NASDAQ: ARDS ) aTyr Pharma Inc (NASDAQ: LIFE ) AVEO Pharmaceuticals, Inc.
   Competition Council president Bogdan Chiritoiu elected to ACER Board of Directors  2019/11/15 21:53:58 Stiri pe surse
President of the Competition Council, Bogdan Chiritoiu, was elected on Friday as a member of the Board of Directors of the European Agency for the Cooperation of Energy Regulators (ACER). Citește mai departe…
   Acer Therapeutics (NASDAQ:ACER) Announces Quarterly Earnings Results  2019/11/15 00:02:41 Modern Readers
Acer Therapeutics (NASDAQ:ACER) posted its quarterly earnings results on Wednesday. The biopharmaceutical company reported ($0.52) earnings per share for the quarter, beating the consensus estimate of ($0.57) by $0.05, Yahoo Finance reports. Shares of ACER stock traded down $0.27 on Thursday, hitting $3.13. 54,906 shares of the company’s stock traded hands, compared to its average […]
   The Daily Biotech Pulse: Roche Snags Double Nod For Personalized Cancer Drug, Bellicum Offering, Nabriva Braces For Contepo Resubmission  2019/08/16 11:33:27 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 15) Novocure Ltd (NASDAQ: NVCR ) Down In The Dumps (Biotech stocks hitting 52-week lows on Aug. 15) AbbVie Inc (NYSE: ABBV ) Acer Therapeutics Inc (NASDAQ: ACER ) Adaptimmune Therapeutics PLC – ADR (NASDAQ: ADAP ) Aerpio Pharmaceuticals Inc (NASDAQ: ARPO ) Aldeyra Therapeutics Inc (NASDAQ: ALDX ) Amneal Pharmaceuticals Inc (NYSE: AMRX ) Alector Inc (NASDAQ: ALEC ) ANCHIANO THERAP/S ADR (NASDAQ: ANCN ) Bellicum Pharmaceuticals Inc (NASDAQ: BLCM ) BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX ) BioTelemetry Inc (NASDAQ: BEAT ) Cellectis SA (NASDAQ: CLLS ) Cyclerion Therapeutics Inc (NASDAQ: CYCN ) DelMar Pharmaceuticals Inc (NASDAQ: DMPI )(announced pricing of its $6.5 million common stock offering at $1 per share) Eton Pharmaceuticals Inc (NASDAQ: ETON ) Fulcrum Therapeutics Inc (NASDAQ: FULC ) Gemphire Therapeutics Inc (NASDAQ: GEMP ) Genetic Technologies Limited (NASDAQ: GENE ) GENFIT S A/ADR (NASDAQ: GNFT ) HTG Molecular Diagnostics Inc (NASDAQ: HTGM ) Idera Pharmaceuticals Inc (NASDAQ: IDRA ) Innovate Biopharmaceuticals Inc (NASDAQ: INNT ) Ironwood Pharmaceuticals, Inc.
   The Daily Biotech Pulse: Mallinkckrodt's Terlipressin, Deciphera Offering, Sellas Reboots On Earnings  2019/08/15 11:45:19 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 14) GENMAB A/S/S ADR (NASDAQ: GMAB ) (announced first-half results and raised 2019 guidance) Down In The Dumps (Biotech stocks hitting 52-week lows on Aug. 14) Acer Therapeutics Inc (NASDAQ: ACER ) (reacted to second-quarter results) Acorda Therapeutics Inc (NASDAQ: ACOR ) Adaptimmune Therapeutics PLC – ADR (NASDAQ: ADAP ) Akorn, Inc. (NASDAQ: AKRX ) Amneal Pharmaceuticals Inc (NYSE: AMRX ) aTyr Pharma Inc (NASDAQ: LIFE ) (reacted to second-quarter results) Bicycle Therapeutics PLC (NASDAQ: BCYC ) BioMarin Pharmaceutical Inc. (NASDAQ: BMRN ) Cancer Genetics Inc (NASDAQ: CGIX ) Cellectis SA (NASDAQ: CLLS ) DelMar Pharmaceuticals Inc (NASDAQ: DMPI )(announced $6.5 million common stock offering) DiaMedica Therapeutics Inc (NASDAQ: DMAC )(reacted to second-quarter results) Ekso Bionics Holdings Inc (NASDAQ: EKSO ) Fulcrum Therapeutics Inc (NASDAQ: FULC ) GENFIT S A/ADR (NASDAQ: GNFT ) Kiniksa Pharmaceuticals Ltd (NASDAQ: KNSA ) Medigus ADR (NASDAQ: MDGS ) Meridian Bioscience, Inc.
   The Daily Biotech Pulse: Mylan Ramps Up Manufacturing Of Potential COVID-19 Drug, Lexicon Stops Study Early, Masimo To Buy German Ventilation Company  2020/03/20 11:44:59 Benzinga Feeds
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 19.) Biomerica, Inc. (NASDAQ: BMRA ) Centogene NV (NASDAQ: CNTG ) Gilead Sciences, Inc. (NASDAQ: GILD ) Imara Inc (NASDAQ: IMRA ) Regeneron Pharmaceuticals Inc (NASDAQ: REGN ) Down In The Dumps (Biotech stocks that hit 52-week lows March 19.) Acasti Pharma Inc (NASDAQ: ACST ) Accelerate Diagnostics Inc (NASDAQ: AXDX ) Acer Therapeutics Inc (NASDAQ: ACER ) Aclaris Therapeutics Inc (NASDAQ: ACRS ) Aerpio Pharmaceuticals Inc (NASDAQ: ARPO ) Aikido Pharma Inc (NASDAQ: AIKI ) Alpine Immune Sciences Inc (NASDAQ: ALPN ) Amphastar Pharmaceuticals Inc (NASDAQ: AMPH ) Anika Therapeutics Inc (NASDAQ: ANIK ) Anixa Biosciences Inc (NASDAQ: ANIX ) AnPac Bio-Medical Science Co Ltd – ADR (NASDAQ: ANPC ) Antares Pharma Inc (NASDAQ: ATRS ) Apyx Medical Corp (NASDAQ: APYX ) Arca Biopharma Inc (NASDAQ: ABIO ) Aridis Pharmaceuticals Inc (NASDAQ: ARDS ) aTyr Pharma Inc (NASDAQ: LIFE ) AVEO Pharmaceuticals, Inc.
   Competition Council president Bogdan Chiritoiu elected to ACER Board of Directors  2019/11/15 21:53:58 Stiri pe surse
President of the Competition Council, Bogdan Chiritoiu, was elected on Friday as a member of the Board of Directors of the European Agency for the Cooperation of Energy Regulators (ACER). Citește mai departe…
   Acer Therapeutics (NASDAQ:ACER) Announces Quarterly Earnings Results  2019/11/15 00:02:41 Modern Readers
Acer Therapeutics (NASDAQ:ACER) posted its quarterly earnings results on Wednesday. The biopharmaceutical company reported ($0.52) earnings per share for the quarter, beating the consensus estimate of ($0.57) by $0.05, Yahoo Finance reports. Shares of ACER stock traded down $0.27 on Thursday, hitting $3.13. 54,906 shares of the company’s stock traded hands, compared to its average […]
   The Daily Biotech Pulse: Roche Snags Double Nod For Personalized Cancer Drug, Bellicum Offering, Nabriva Braces For Contepo Resubmission  2019/08/16 11:33:27 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 15) Novocure Ltd (NASDAQ: NVCR ) Down In The Dumps (Biotech stocks hitting 52-week lows on Aug. 15) AbbVie Inc (NYSE: ABBV ) Acer Therapeutics Inc (NASDAQ: ACER ) Adaptimmune Therapeutics PLC – ADR (NASDAQ: ADAP ) Aerpio Pharmaceuticals Inc (NASDAQ: ARPO ) Aldeyra Therapeutics Inc (NASDAQ: ALDX ) Amneal Pharmaceuticals Inc (NYSE: AMRX ) Alector Inc (NASDAQ: ALEC ) ANCHIANO THERAP/S ADR (NASDAQ: ANCN ) Bellicum Pharmaceuticals Inc (NASDAQ: BLCM ) BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX ) BioTelemetry Inc (NASDAQ: BEAT ) Cellectis SA (NASDAQ: CLLS ) Cyclerion Therapeutics Inc (NASDAQ: CYCN ) DelMar Pharmaceuticals Inc (NASDAQ: DMPI )(announced pricing of its $6.5 million common stock offering at $1 per share) Eton Pharmaceuticals Inc (NASDAQ: ETON ) Fulcrum Therapeutics Inc (NASDAQ: FULC ) Gemphire Therapeutics Inc (NASDAQ: GEMP ) Genetic Technologies Limited (NASDAQ: GENE ) GENFIT S A/ADR (NASDAQ: GNFT ) HTG Molecular Diagnostics Inc (NASDAQ: HTGM ) Idera Pharmaceuticals Inc (NASDAQ: IDRA ) Innovate Biopharmaceuticals Inc (NASDAQ: INNT ) Ironwood Pharmaceuticals, Inc.
   The Daily Biotech Pulse: Mallinkckrodt's Terlipressin, Deciphera Offering, Sellas Reboots On Earnings  2019/08/15 11:45:19 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 14) GENMAB A/S/S ADR (NASDAQ: GMAB ) (announced first-half results and raised 2019 guidance) Down In The Dumps (Biotech stocks hitting 52-week lows on Aug. 14) Acer Therapeutics Inc (NASDAQ: ACER ) (reacted to second-quarter results) Acorda Therapeutics Inc (NASDAQ: ACOR ) Adaptimmune Therapeutics PLC – ADR (NASDAQ: ADAP ) Akorn, Inc. (NASDAQ: AKRX ) Amneal Pharmaceuticals Inc (NYSE: AMRX ) aTyr Pharma Inc (NASDAQ: LIFE ) (reacted to second-quarter results) Bicycle Therapeutics PLC (NASDAQ: BCYC ) BioMarin Pharmaceutical Inc. (NASDAQ: BMRN ) Cancer Genetics Inc (NASDAQ: CGIX ) Cellectis SA (NASDAQ: CLLS ) DelMar Pharmaceuticals Inc (NASDAQ: DMPI )(announced $6.5 million common stock offering) DiaMedica Therapeutics Inc (NASDAQ: DMAC )(reacted to second-quarter results) Ekso Bionics Holdings Inc (NASDAQ: EKSO ) Fulcrum Therapeutics Inc (NASDAQ: FULC ) GENFIT S A/ADR (NASDAQ: GNFT ) Kiniksa Pharmaceuticals Ltd (NASDAQ: KNSA ) Medigus ADR (NASDAQ: MDGS ) Meridian Bioscience, Inc.
   Competition Council president Bogdan Chiritoiu elected to ACER Board of Directors  2019/11/15 21:53:58 Stiri pe surse
President of the Competition Council, Bogdan Chiritoiu, was elected on Friday as a member of the Board of Directors of the European Agency for the Cooperation of Energy Regulators (ACER). Citește mai departe…
   Acer Therapeutics (NASDAQ:ACER) Announces Quarterly Earnings Results  2019/11/15 00:02:41 Modern Readers
Acer Therapeutics (NASDAQ:ACER) posted its quarterly earnings results on Wednesday. The biopharmaceutical company reported ($0.52) earnings per share for the quarter, beating the consensus estimate of ($0.57) by $0.05, Yahoo Finance reports. Shares of ACER stock traded down $0.27 on Thursday, hitting $3.13. 54,906 shares of the company’s stock traded hands, compared to its average […]
   The Daily Biotech Pulse: Roche Snags Double Nod For Personalized Cancer Drug, Bellicum Offering, Nabriva Braces For Contepo Resubmission  2019/08/16 11:33:27 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 15) Novocure Ltd (NASDAQ: NVCR ) Down In The Dumps (Biotech stocks hitting 52-week lows on Aug. 15) AbbVie Inc (NYSE: ABBV ) Acer Therapeutics Inc (NASDAQ: ACER ) Adaptimmune Therapeutics PLC – ADR (NASDAQ: ADAP ) Aerpio Pharmaceuticals Inc (NASDAQ: ARPO ) Aldeyra Therapeutics Inc (NASDAQ: ALDX ) Amneal Pharmaceuticals Inc (NYSE: AMRX ) Alector Inc (NASDAQ: ALEC ) ANCHIANO THERAP/S ADR (NASDAQ: ANCN ) Bellicum Pharmaceuticals Inc (NASDAQ: BLCM ) BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX ) BioTelemetry Inc (NASDAQ: BEAT ) Cellectis SA (NASDAQ: CLLS ) Cyclerion Therapeutics Inc (NASDAQ: CYCN ) DelMar Pharmaceuticals Inc (NASDAQ: DMPI )(announced pricing of its $6.5 million common stock offering at $1 per share) Eton Pharmaceuticals Inc (NASDAQ: ETON ) Fulcrum Therapeutics Inc (NASDAQ: FULC ) Gemphire Therapeutics Inc (NASDAQ: GEMP ) Genetic Technologies Limited (NASDAQ: GENE ) GENFIT S A/ADR (NASDAQ: GNFT ) HTG Molecular Diagnostics Inc (NASDAQ: HTGM ) Idera Pharmaceuticals Inc (NASDAQ: IDRA ) Innovate Biopharmaceuticals Inc (NASDAQ: INNT ) Ironwood Pharmaceuticals, Inc.
   The Daily Biotech Pulse: Mallinkckrodt's Terlipressin, Deciphera Offering, Sellas Reboots On Earnings  2019/08/15 11:45:19 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 14) GENMAB A/S/S ADR (NASDAQ: GMAB ) (announced first-half results and raised 2019 guidance) Down In The Dumps (Biotech stocks hitting 52-week lows on Aug. 14) Acer Therapeutics Inc (NASDAQ: ACER ) (reacted to second-quarter results) Acorda Therapeutics Inc (NASDAQ: ACOR ) Adaptimmune Therapeutics PLC – ADR (NASDAQ: ADAP ) Akorn, Inc. (NASDAQ: AKRX ) Amneal Pharmaceuticals Inc (NYSE: AMRX ) aTyr Pharma Inc (NASDAQ: LIFE ) (reacted to second-quarter results) Bicycle Therapeutics PLC (NASDAQ: BCYC ) BioMarin Pharmaceutical Inc. (NASDAQ: BMRN ) Cancer Genetics Inc (NASDAQ: CGIX ) Cellectis SA (NASDAQ: CLLS ) DelMar Pharmaceuticals Inc (NASDAQ: DMPI )(announced $6.5 million common stock offering) DiaMedica Therapeutics Inc (NASDAQ: DMAC )(reacted to second-quarter results) Ekso Bionics Holdings Inc (NASDAQ: EKSO ) Fulcrum Therapeutics Inc (NASDAQ: FULC ) GENFIT S A/ADR (NASDAQ: GNFT ) Kiniksa Pharmaceuticals Ltd (NASDAQ: KNSA ) Medigus ADR (NASDAQ: MDGS ) Meridian Bioscience, Inc.
   The Daily Biotech Pulse: Jazz Goes Shopping, Portola Offering, Novelion Delays Quarterly Results  2019/08/13 11:25:15 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 12) GENMAB A/S/S ADR (NASDAQ: GMAB ) (IPOed July 1) Down In The Dumps (Biotech stocks hitting 52-week lows on Aug. 13) Acer Therapeutics Inc (NASDAQ: ACER ) Aclaris Therapeutics Inc (NASDAQ: ACRS ) Adaptimmune Therapeutics PLC – ADR (NASDAQ: ADAP ) Adial Pharmaceuticals Inc (NASDAQ: ADIL ) Advaxis, Inc. (NASDAQ: ADXS ) AnaptysBio Inc (NASDAQ: ANAB ) Autolus Therapeutics Ltd – ADR (NASDAQ: AUTL ) BioMarin Pharmaceutical Inc. (NASDAQ: BMRN ) Cyclacel Pharmaceuticals Inc (NASDAQ: CYCC ) Fulcrum Therapeutics Inc (NASDAQ: FULC ) Gamida Cell Ltd (NASDAQ: GMDA ) GENFIT S A/ADR (NASDAQ: GNFT ) Hemispherx BioPharma, Inc (NYSE: HEB ) Homology Medicines Inc (NASDAQ: FIXX ) INmune Bio Inc (NASDAQ: INMB )(reacted to second quarter results) Innovate Biopharmaceuticals Inc (NASDAQ: INNT ) Mallinckrodt PLC (NYSE: MNK )(was accused by Humana Inc (NYSE: HUM ) of manipulating prices of Achtar) Mersana Therapeutics Inc (NASDAQ: MRSN ) Novavax, Inc. (NASDAQ: NVAX )(reported new data from the Phase 3 trial dubbed PREPARE that evaluated its ResVax ) Obalon Therapeutics Inc (NASDAQ: OBLN ) Pfizer Inc. (NYSE: PFE ) Plus Therapeutics Inc (NASDAQ: PSTV ) Proteostasis …

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 オペクサ・セラピュ―ティクス ACER Acer Therapeutics Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)